Growth Metrics

Cartesian Therapeutics (RNAC) Shares Outstanding: 2015-2016

  • Cartesian Therapeutics' Shares Outstanding was N/A to $17.9 million in Q2 2016 from the same period last year, while for Jun 2016 it was $17.9 million, marking a year-over-year change of. This contributed to the annual value of $2.2 million for FY2015, which is N/A change from last year.
  • According to the latest figures from Q2 2016, Cartesian Therapeutics' Shares Outstanding is $17.9 million, which was up 723.40% from $2.2 million recorded in Q4 2015.
  • Over the past 5 years, Cartesian Therapeutics' Shares Outstanding peaked at $17.9 million during Q2 2016, and registered a low of $2.2 million during Q4 2015.
  • For the 2-year period, Cartesian Therapeutics' Shares Outstanding averaged around $10.0 million, with its median value being $10.0 million (2015).